JOHNSON DAVID LEE 4
4 · Caribou Biosciences, Inc. · Filed Feb 23, 2023
Insider Transaction Report
Form 4
JOHNSON DAVID LEE
Director
Transactions
- Award
Option to purchase Common Stock
2023-02-21+21,500→ 21,500 totalExercise: $6.12Exp: 2033-02-20→ Common Stock (21,500 underlying)
Footnotes (1)
- [F1]One-twelfth of the shares subject to this option will vest on each monthly anniversary of the grant date such that the option will be fully vested on February 21, 2024, subject to the reporting person continuing to provide service to the Issuer through each such vesting date.